EFFECTS OF TOFACITINIB MONOTHERAPY VERSUS METHOTREXATE ON PATIENT-REPORTED OUTCOMES IN THE 2-YEAR PHASE 3 ORAL START TRIAL IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS

被引：3
|
作者：
Alten, R. [1 ]
Strand, V. [2 ]
Fleischmann, R. [3 ]
Koncz, T. [4 ]
Zwillich, S. [4 ]
Bradley, J. [4 ]
Gruben, D. [4 ]
Wilkinson, B. [4 ]
Krishnaswami, S. [4 ]
Wallenstein, G. [4 ]
机构：
[1] Univ Med, Schlosspk Klin, Berlin, Germany
[2] Biopharmaceut Consultant, Portola Valley, CA USA
[3] Metroplex Clin Res Ctr, Dallas, TX USA
[4] Pfizer Inc, Groton, CT 06340 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.3168
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0152
引用
收藏
页码：118 / 119
页数：2
相关论文
共 50 条
  • [1] ORAL START: EFFECTS OF THE ORAL JAK INHIBITOR TOFACITINIB MONOTHERAPY VERSUS METHOTREXATE ON PATIENT-REPORTED OUTCOMES IN THE PHASE 3 ORAL START TRIAL OF ACTIVE RHEUMATOID ARTHRITIS
    Strand, V.
    Fleischmann, R.
    Alten, R. E.
    Koncz, T.
    Zwillich, S. H.
    Bradley, J. D.
    Gruben, D.
    Wilkinson, B.
    Krishaswami, S.
    Wallenstein, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 252 - 253
  • [2] Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
    Strand, Vibeke
    Lee, Eun Bong
    Fleischmann, Roy
    Alten, Rieke E.
    Koncz, Tamas
    Zwillich, Samuel H.
    Gruben, David
    Wilkinson, Bethanie
    Krishnaswami, Sriram
    Wallenstein, Gene
    RMD OPEN, 2016, 2 (02):
  • [3] Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis: Radiographic, Clinical and Functional Comparison
    Fleischmann, R. M.
    Lee, E. B.
    Hall, S.
    Wilkinson, B. E.
    Bradley, John D.
    Gruben, D.
    Koncz, T.
    Krishnaswami, S.
    Wallenstein, G.
    Zwillich, S. H.
    van Vollenhoven, R. F.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3323
  • [4] RELATIONSHIP BETWEEN DIFFERENT CLINICAL MEASUREMENTS AND PATIENT-REPORTED OUTCOMES: RESULTS FROM A PHASE 3 STUDY OF TOFACITINIB OR METHOTREXATE IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Fleischmann, R.
    Strand, V.
    Wilkinson, B.
    Kwok, K.
    Bananis, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 259 - 260
  • [5] Radiographic, Clinical and Functional Comparison of Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis.
    Lee, Eun Bong
    Fleischmann, Roy M.
    Hall, Stephen
    van Vollenhoven, Ronald F.
    Bradley, John
    Gruben, David
    Koncz, Tamas
    Krishnaswami, Sriram
    Wallenstein, Gene
    Zwillich, Samuel H.
    Wilkinson, Bethanie E.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1049 - S1049
  • [6] Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
    Fleischmann, Roy M.
    Huizinga, Tom W. J.
    Kavanaugh, Arthur F.
    Wilkinson, Bethanie
    Kwok, Kenneth
    DeMasi, Ryan
    van Vollenhoven, Ronald F.
    RMD OPEN, 2016, 2 (02):
  • [7] Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
    Strand, Vibeke
    Mysler, Eduardo
    Moots, Robert J.
    Wallenstein, Gene, V
    DeMasi, Ryan
    Gruben, David
    Soma, Koshika
    Iikuni, Noriko
    Smolen, Josef S.
    Fleischmann, Roy
    RMD OPEN, 2019, 5 (02):
  • [8] Tofacitinib with and without Methotrexate Versus Adalimumab with Methotrexate for the Treatment of Rheumatoid Arthritis: Patient-Reported Outcomes from a Phase 3b/4 Randomized Trial
    Strand, Vibeke
    Mysler, Eduardo
    Moots, Robert J.
    Wallenstein, Gene
    DeMasi, Ryan
    Luo, Zhen
    Soma, Koshika
    Iikuni, Noriko
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] TOFACITINIB WITH AND WITHOUT METHOTREXATE VERSUS ADALIMUMAB WITH METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: PATIENT-REPORTED OUTCOMES FROM A PHASE 3B/4 RANDOMISED TRIAL
    Strand, V.
    Mysler, E.
    Moots, R. J.
    Wallenstein, G.
    DeMasi, R.
    Gruben, D.
    Soma, K.
    Iikuni, N.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 990 - 991
  • [10] Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naive Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo M.
    Ueki, Yukitaka
    Atsumi, Tatsuya
    Chen, Su
    Friedman, Alan
    Pangan, Aileen L.
    Strand, Vibeke
    van Vollenhoven, Ronald F.
    MODERN RHEUMATOLOGY, 2021, 31 (03) : 534 - 542
12345